Tilray Brands Inc (TLRY)
1.84
+0.12
(+6.98%)
USD |
NASDAQ |
Apr 23, 16:00
1.83
-0.01
(-0.54%)
After-Hours: 07:06
Tilray Brands Gross Profit (Quarterly): 49.40M for Feb. 29, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 49.40M |
November 30, 2023 | 47.41M |
August 31, 2023 | 44.20M |
May 31, 2023 | 67.16M |
February 28, 2023 | -11.70M |
November 30, 2022 | 42.88M |
August 31, 2022 | 48.61M |
May 31, 2022 | -6.733M |
February 28, 2022 | 39.83M |
November 30, 2021 | 32.77M |
August 31, 2021 | 50.96M |
May 31, 2021 | 22.50M |
February 28, 2021 | 30.46M |
November 30, 2020 | 35.28M |
August 31, 2020 | 34.94M |
May 31, 2020 | -11.87M |
February 29, 2020 | 44.47M |
November 30, 2019 | 29.79M |
August 31, 2019 | 33.98M |
May 31, 2019 | 15.34M |
February 28, 2019 | 13.16M |
November 30, 2018 | 4.506M |
August 31, 2018 | 10.60M |
May 31, 2018 | 13.96M |
February 28, 2018 | 6.709M |
Date | Value |
---|---|
November 30, 2017 | 4.819M |
August 31, 2017 | 6.261M |
May 31, 2017 | 4.142M |
February 28, 2017 | 2.706M |
November 30, 2016 | 3.067M |
August 31, 2016 | 2.889M |
May 31, 2016 | 1.726M |
February 29, 2016 | 1.390M |
November 30, 2015 | 0.9792M |
August 31, 2015 | 0.5124M |
May 31, 2015 | 0.4724M |
February 28, 2015 | 0.2057M |
November 30, 2014 | |
August 31, 2014 | |
May 31, 2014 | |
February 28, 2014 | |
November 30, 2013 | |
August 31, 2013 | |
May 31, 2013 | |
February 28, 2013 | |
November 30, 2012 | |
August 31, 2012 | |
May 31, 2012 | |
February 29, 2012 | |
November 30, 2011 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-11.87M
Minimum
May 2020
67.16M
Maximum
May 2023
31.98M
Average
35.11M
Median
Gross Profit (Quarterly) Benchmarks
Clever Leaves Holdings Inc | -0.346M |
Flora Growth Corp | 3.49M |
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 39.70M |
Edesa Biotech Inc | -- |